PL2555789T3 - Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania - Google Patents

Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania

Info

Publication number
PL2555789T3
PL2555789T3 PL11718957T PL11718957T PL2555789T3 PL 2555789 T3 PL2555789 T3 PL 2555789T3 PL 11718957 T PL11718957 T PL 11718957T PL 11718957 T PL11718957 T PL 11718957T PL 2555789 T3 PL2555789 T3 PL 2555789T3
Authority
PL
Poland
Prior art keywords
trem
tlt
transcript
peptides derived
inhibiting peptides
Prior art date
Application number
PL11718957T
Other languages
English (en)
Inventor
Sébastien GIBOT
Marc Derive
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Université De Lorraine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Université De Lorraine filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Publication of PL2555789T3 publication Critical patent/PL2555789T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL11718957T 2010-04-08 2011-04-08 Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania PL2555789T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10305364 2010-04-08
PCT/EP2011/055519 WO2011124685A1 (en) 2010-04-08 2011-04-08 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
EP11718957.1A EP2555789B1 (en) 2010-04-08 2011-04-08 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof

Publications (1)

Publication Number Publication Date
PL2555789T3 true PL2555789T3 (pl) 2021-02-08

Family

ID=42262363

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11718957T PL2555789T3 (pl) 2010-04-08 2011-04-08 Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania

Country Status (19)

Country Link
US (2) US9255136B2 (pl)
EP (2) EP3741383A1 (pl)
JP (2) JP5918750B2 (pl)
CN (1) CN103153327B (pl)
AU (1) AU2011237851B2 (pl)
CA (1) CA2795390C (pl)
CY (1) CY1123304T1 (pl)
DK (1) DK2555789T3 (pl)
ES (1) ES2805301T3 (pl)
HR (1) HRP20201081T1 (pl)
HU (1) HUE050815T2 (pl)
LT (1) LT2555789T (pl)
NZ (1) NZ602845A (pl)
PL (1) PL2555789T3 (pl)
PT (1) PT2555789T (pl)
RS (1) RS60636B1 (pl)
SI (1) SI2555789T1 (pl)
SM (1) SMT202000407T1 (pl)
WO (1) WO2011124685A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
MX385794B (es) * 2012-09-07 2025-03-18 Inst Nat Sante Rech Med Péptidos inhibidores obtenidos del receptor desencadenante expresado en células mieloides de tipo 1 (trem-1) y transcrito similar a trem 1 (tlt-1) y usos de los mismos.
KR101404098B1 (ko) * 2012-11-29 2014-06-05 성균관대학교산학협력단 금속 나노와이어-유기화합물 복합체, 이를 포함하는 필름, 및 이의 제조 방법
RU2757489C2 (ru) * 2015-06-12 2021-10-18 Маккэй Медикл Фаундэйшн Зе Пресбайтериэн Чёч Ин Тайвэнь Маккэй Мемориал Хоспитэл Способы и антитела для модуляции иммунного ответа
JOP20190248A1 (ar) 2017-04-21 2019-10-20 Amgen Inc بروتينات ربط مولد ضد trem2 واستخداماته
CN108276488B (zh) * 2018-01-26 2020-06-19 四川农业大学 一种鸡髓样细胞触发受体b2多克隆抗体及其制备方法和应用
WO2020036987A1 (en) 2018-08-13 2020-02-20 Signablok, Inc. Peptides and compositions for targeted treatment and imaging
EP4474013A3 (en) * 2018-09-28 2025-02-26 Inotrem Use of soluble trem-1 levels for identifying subjects susceptible to respond to an anti-inflammatory therapy
PE20212262A1 (es) 2019-04-17 2021-11-29 Novo Nordisk As Anticuerpos biespecificos
WO2021144388A1 (en) 2020-01-15 2021-07-22 Fresenius Kabi Ipsum S.R.L. Process for the synthesis of nangibotide
US12661396B2 (en) 2020-05-14 2026-06-23 Ascendo Biotechnology, Inc. Selective targeting of the TREML1/MD2 interaction by small peptide or protein and its use for vaccine adjuvants
US20230201301A1 (en) * 2020-06-05 2023-06-29 Inotrem Trem-1 inhibitor for use in the treatment of a subject suffering from a coronavirus infection
CN117715940A (zh) 2021-06-02 2024-03-15 伊诺特伦公司 抗trem-1抗体
CN113755580B (zh) * 2021-09-13 2023-10-27 中国医学科学院阜外医院 一种治疗和/或缓解淋巴水肿的药物干预靶点及其应用
WO2024153243A1 (zh) * 2023-01-19 2024-07-25 武汉人福创新药物研发中心有限公司 作为Trem-1抑制剂的修饰肽

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2005261A (en) 1933-05-24 1935-06-18 Leland Electric Co Riveting machine
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
ATE318832T1 (de) 1990-06-11 2006-03-15 Gilead Sciences Inc Verfahren zur vervendung von nukleinsäureliganden
JP3866760B2 (ja) 1993-02-22 2007-01-10 ザ ロックフェラー ユニバーシティ 一過性トランスフェクションによる高力価のヘルパーフリーのレトロウイルスの生産
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US7129072B1 (en) 1999-08-30 2006-10-31 New York University Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor
WO2001043695A2 (en) 1999-10-27 2001-06-21 Cel-Sci Corporation Peptide constructs for treating autoimmune and related diseases
JP2001210726A (ja) * 2000-01-24 2001-08-03 Hitachi Ltd 半導体装置及びその製造方法
EP1289552B1 (en) * 2000-05-19 2006-03-29 The Center for Blood Research, INC. Methods for treating hemostatic disorders by soluble p-selectin
AU2001274947B2 (en) * 2000-05-23 2006-08-17 Acorda Therapeutics, Inc. Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
EP1434787A4 (en) * 2001-09-05 2006-06-07 Lilly Co Eli LP MAMMALIAN PROTEINS AND REAGENTS
US20040180409A1 (en) 2003-03-16 2004-09-16 Mcvicar Daniel TLT-1, a novel platelet-associated receptor and uses therefor
GB0426146D0 (en) * 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
US20130332133A1 (en) 2006-05-11 2013-12-12 Ramot At Tel Aviv University Ltd. Classification of Protein Sequences and Uses of Classified Proteins
US7553936B2 (en) * 2006-12-04 2009-06-30 The United States of America as represented by Secretary Department of Health and Human Services Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
WO2010132370A2 (en) 2009-05-11 2010-11-18 Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Soluble tlt-1 for the treatment and diagnosis of sepsis

Also Published As

Publication number Publication date
HUE050815T2 (hu) 2021-01-28
SI2555789T1 (sl) 2020-10-30
LT2555789T (lt) 2020-09-25
US9255136B2 (en) 2016-02-09
NZ602845A (en) 2015-05-29
CA2795390A1 (en) 2011-10-13
CY1123304T1 (el) 2021-12-31
EP2555789B1 (en) 2020-06-10
HRP20201081T1 (hr) 2021-01-22
WO2011124685A1 (en) 2011-10-13
JP2013523140A (ja) 2013-06-17
JP5918750B2 (ja) 2016-05-18
US20130029921A1 (en) 2013-01-31
EP2555789A1 (en) 2013-02-13
EP3741383A1 (en) 2020-11-25
PT2555789T (pt) 2020-07-14
AU2011237851B2 (en) 2015-02-05
RS60636B1 (sr) 2020-09-30
CA2795390C (en) 2020-11-03
DK2555789T3 (da) 2020-07-20
AU2011237851A1 (en) 2012-11-01
CN103153327B (zh) 2016-01-20
JP2016169208A (ja) 2016-09-23
ES2805301T3 (es) 2021-02-11
SMT202000407T1 (it) 2020-09-10
US9815883B2 (en) 2017-11-14
CN103153327A (zh) 2013-06-12
US20160015773A1 (en) 2016-01-21

Similar Documents

Publication Publication Date Title
PT2555789T (pt) Péptidos inibidores derivados do transcrito 1 tipo-trem (tlt-1) e seus usos
IL219882A0 (en) System for increasing gene expression and vector comprising the system
GB0914110D0 (en) Peptide libraries
SMT202200422T1 (it) Sistema di deposito comprendente glatiramer acetato
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
IL219701A0 (en) Compositions comprising r-g-cysteic acid peptides and uses thereof
GB201012651D0 (en) Peptides
EP2593595A4 (en) NOVEL PEPTIDES AND USES THEREOF
EP2521564A4 (en) APOE PEPTIDE DIMERS AND USES THEREOF
LT2538972T (lt) Rekombinantinės cdv kompozicijos ir jų panaudojimas
PL2627668T3 (pl) Peptydy i ich zastosowanie
EP2471553A4 (en) IMMUNOGENIC COMPOSITION WITH PEPTIDES FROM CYTOMEGALOVIRUS AND THEIR USE
PL2464656T3 (pl) Nowy peptyd i jego zastosowanie
IL216199A (en) A peptide containing the sequence ednimvtfrnqasr
PL3346273T3 (pl) Nowe, pochodzące od d3 d-enancjomeryczne peptydy i ich zastosowanie
PL2396345T3 (pl) Peptydy przeciwdrobnoustrojowe na bazie CMAP27
IL213026A0 (en) TNA-a INHIBITING PEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
IL225464B (en) 2nd peptides, preparations containing them and their uses
SG173752A1 (en) Modifications of cupredoxin derived peptides and methods of use thereof
IL225405A0 (en) Methods for immune modulation and systems for the treatment and/or prevention of atherosclerosis, proteins, peptides and preparations.
ZA201203722B (en) Peptide
GB2489887B (en) Cover for a laparoscope, systems including the cover and methods of use
WO2011087491A9 (en) Parstatin peptides and uses thereof
TWI369211B (en) An isolated peptide and the preparation processes and applications thereof
IL215268A0 (en) C6orf167 peptides and vaccines containing the same